Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 74431-23-5 Chemical Structure| 74431-23-5

Structure of Imipenem monohydrate
CAS No.: 74431-23-5

Chemical Structure| 74431-23-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Imipenem monohydrate is a broad-spectrum β-lactam antibiotic with high efficacy against various Gram-positive and Gram-negative bacteria, with a MIC value of 0.06-0.5 μg/mL. Imipenem monohydrate is mainly used in research on the treatment of severe bacterial infections.

Synonyms: N-Formimidoyl thienamycin monohydrate; MK0787 monohydrate; N-Formimidoyl Thienamycin

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Imipenem monohydrate

CAS No. :74431-23-5
Formula : C12H19N3O5S
M.W : 317.36
SMILES Code : O=C(C(N12)=C(SCCNC=N)C[C@]2([H])[C@@H]([C@H](O)C)C1=O)O.[H]O[H]
Synonyms :
N-Formimidoyl thienamycin monohydrate; MK0787 monohydrate; N-Formimidoyl Thienamycin
English Name :(5R,6S)-3-((2-Formimidamidoethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate
MDL No. :MFCD09753321
InChI Key :GSOSVVULSKVSLQ-JJVRHELESA-N
Pubchem ID :5282372

Safety of Imipenem monohydrate

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice MHC-matched minor antigen-mismatched allo-HSCT mouse model Subcutaneous injection 100 mg/kg Three times per week, from day 10 to day 24 post-transplant To investigate the effect of imipenem-cilastatin on GVHD severity, results showed that imipenem-cilastatin treatment significantly increased GVHD-related mortality. Sci Transl Med. 2016 May 18;8(339):339ra71
Mice 8-week-old male mice Intraperitoneal injection 25, 40, or 65 μg IMP-BMV Single injection, monitored for 5 days To evaluate the lethality of BMVs in mice. Results showed that IMP-BMV induced lower mortality compared to CAZ-BMV. Virulence. 2020 Dec;11(1):145-158

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01381549 Infections, Urinary Tract Phase 2 Terminated(Microbiological fin... More >>dings of resistance on therapy in patients with complicated urinary tract infection) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90033 United States, Iowa GSK Investigational Site Council Bluffs, Iowa, United States, 51503 United States, Kansas GSK Investigational Site Topeka, Kansas, United States, 66604 United States, Texas GSK Investigational Site Corsicana, Texas, United States, 75110 Canada, Quebec GSK Investigational Site Chicoutimi, Quebec, Canada, G7H 5H6 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 France GSK Investigational Site Suresnes, France, 92151 GSK Investigational Site Toulouse cedex 9, France, 31059 Greece GSK Investigational Site Athens, Greece, 11527 GSK Investigational Site Chaidari, Greece, 12462 GSK Investigational Site Goudi, Athens, Greece, 11527 GSK Investigational Site Thessaloniki, Greece, 56429 Russian Federation GSK Investigational Site Irkutsk, Russian Federation, 664079 GSK Investigational Site Moscow, Russian Federation, 125367 GSK Investigational Site Rostov-on-Don, Russian Federation, 344022 GSK Investigational Site Smolensk, Russian Federation, 214018 GSK Investigational Site St'Petersburg, Russian Federation, 194354 Spain GSK Investigational Site Alicante, Spain, 03010 GSK Investigational Site Elche (Alicante), Spain, 03203 GSK Investigational Site Getafe/Madrid, Spain, 28905 GSK Investigational Site Granada, Spain, 18003 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Murcia, Spain GSK Investigational Site Pama de Mallorca, Spain, 07010 Less <<
NCT01381549 - Terminated(Microbiological fin... More >>dings of resistance on therapy in patients with complicated urinary tract infection) Less << - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.15mL

0.63mL

0.32mL

15.75mL

3.15mL

1.58mL

31.51mL

6.30mL

3.15mL

References

 

Historical Records

Categories